Similar articles

• Questions regarding BNP assays.

  Schwam E. Schwam E. Ann Emerg Med. 2006 Feb;47(2):213-4; author reply 214. doi: 10.1016/j.annemergmed.2005.08.034. Ann Emerg Med. 2006. PMID: 16431242 No abstract available.
• Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.

  Pahle AS, Sørli D, Omland T, Knudsen CW, Westheim A, Wu AH, Steg PG, McCord J, Nowak RM, Hollander JE, Storrow AB, Abraham WT, McCullough PA, Maisel A. Pahle AS, et al. Am J Cardiol. 2009 Oct 1;104(7):966-71. doi: 10.1016/j.amjcard.2009.05.039. Am J Cardiol. 2009. PMID: 19766765
• Are BNP plasma levels useful in heart failure diagnosis each time? A dyspneic patient with anasarca.

  Parrinello G, Torres D, Paterna S, Trapanese C, Pomilla M, Lupo U, Licata G. Parrinello G, et al. Am J Emerg Med. 2011 Feb;29(2):239.e5-239.e10. doi: 10.1016/j.ajem.2010.02.016. Epub 2010 Jul 13. Am J Emerg Med. 2011. PMID: 20627214 No abstract available.
• [Clinical applications of brain natriuretic peptide testing].

  Scardovi AB; Associazione Nazionale Medici Cardiologi Ospedalieri; Società Italiana di Cardiologia Pediatrica; Società Italiana di Nefrologia Pediatrica; Società Italiana dell'Ipertensione Arteriosa; Società Italiana di Pediatria. Scardovi AB, et al. Ital Heart J Suppl. 2004 May;5(5):343-56. Ital Heart J Suppl. 2004. PMID: 15182061 Review. Italian.
• Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.

  Baggish AL, van Kimmenade RR, Januzzi JL Jr. Baggish AL, et al. Am J Cardiol. 2008 Feb 4;101(3A):49-55. doi: 10.1016/j.amjcard.2007.11.020. Am J Cardiol. 2008. PMID: 18243859 Review.